Dasatinib


- TRADE NAME: Sprycel (Bristol-Myers Squibb)
- INDICATIONS: Leukemia (chronic myeloid); acute lymphoblastic leukemia
- CLASS: Antineoplastic / anticancer agent (see also Immune checkpoint inhibitor), Tyrosine kinase inhibitor, Vascular endothelial growth factor (VEGF) inhibitor / antagonist
- HALF-LIFE: 3–5 hours
Abciximab, Alfentanil, Alfuzosin, Ambrisentan, Antacids, Anticoagulants, Antiplatelet agents, Aprepitant, Argatroban, Artemether/Lumefantrine, Astemizole, Atazanavir, Atorvastatin, Boceprevir, Cabazitaxel, Carbamazepine, Chloroquine, Ciclesonide, Cilostazol, Cinacalcet, Ciprofloxacin, Cisapride, Clarithromycin, Clopidogrel, Clozapine, Colchicine, Conivaptan, Cyclosporine, CYP3A4 inhibitors, inducers and substrates, Dabigatran, Darunavir, Deferasirox, Dexamethasone, Dihydroergotamine, Docetaxel, Dronedarone, Efavirenz, Eptifibatide, Ergotamine, Erythromycin, Eszopiclone, Famotidine, Fentanyl, Fesoterodine, Gadobutrol, Gefitinib, H2 antagonists, Indinavir, Itraconazole, Ixabepilone, Ketoconazole, Lopinavir, Lurasidone, Maraviroc, Meloxicam, Nefazodone, Nelfinavir, Nilotinib, Omeprazole, Pantoprazole, Phenobarbital, Phenytoin, Pimozide, Proton pump inhibitors, QT prolonging agents, Quinidine, Quinine, Rifampin, Ritonavir, Saquinavir, Saxagliptin, Sildenafil, Simvastatin, Sirolimus, St John's Wort, Tacrolimus, Tadalafil, Temsirolimus, Terfenadine, Tetrabenazine, Thioridazine, Tiagabine, Tinzaparin, Vardenafil, Ziprasidone
PREGNANCY CATEGORY: D
Please login to see the rest of this drug profile
Page last updated 07/31/2023
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations 
- Breast feeding
- Geriatric
- Pediatric